Latest Exciva News & Updates

See the latest news and media coverage for Exciva. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Exciva

Biopharmaceutical company developing treatments for neuropsychiatric symptoms of dementia

exciva.com
Founded year
2016
Company type
Private company
Number of employees
9–10
Industry
Pharmaceuticals

Last updated

Latest news about Exciva

Company announcements

Exciva

Exciva appoints Mark Altmeyer as chairman of the board

Altmeyer brings over 35 years of biopharma experience in commercialization, M&A and international expansion. The appointment follows Exciva's €53 million Series B round led by Gimv and EQT Life Sciences.

Exciva

Exciva closes R&D Project Manager vacancy in Germany

The full-time role covered planning and coordination of cross-functional R&D programs from early research through clinical development. It required five or more years of biotech or pharma project management experience and fluency in English and German.

Exciva

Exciva closes €51 million Series B funding round

Gimv and EQT Life Sciences co-led the round, which will mainly fund a phase 2 study of Deraphan for agitation in Alzheimer's disease.

Unlock all announcements with a

Media coverage

Track future articles with a

Never miss news about Exciva

Track Exciva and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.